EUVIMEDEUVIMED entdecken
Crossref

Exploring the Impact of Non‐Ablative Erbium Laser Therapy on Recurrent Vaginal Candidiasis

Adrian Gaspar, Alicia Calderon, Josue Vargas Mora, Joaquin Silva, Juan Fernando Bojanini, Maria Jose Araujo, Leticia Lazzaleta Geada, Elena Ivanova, Yeksin Helvacioglu, Pedro Peña Coello, Delfina Zelaschi, Maria Fernanda Lucas und 5 weitere

Lasers in Surgery and Medicine · 2025-02 · 57 (2) · 187-194

DOI: 10.1002/lsm.23880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 30.01.2025. Verfasst von Adrian Gaspar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Research and Health Department, Champagnat University, Mendoza, Argentina. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Lasers, Solid-State. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the effect of non‐ablative Er:YAG laser therapy on the symptoms and microbiological conditions of women with recurrent vulvovaginal candidiasis (RVVC). Materials and Methods One hundred and sixty‐seven women (mean age 34.1 ± 8.57 years) participated in this cohort study. Women diagnosed with RVVC received four vaginal laser therapies within 4 months. At baseline, 3 months, and 9 months after the last laser therapy microbiological assessment, improvement of five bothersome symptoms related to vaginal infection (burning, itching, dyspareunia, dysuria, and abnormal discharge), and the safety of the laser therapy and overall patient satisfaction were assessed.

Results

Non‐ablative vaginal Er:YAG laser therapy resulted in improvements of all bothersome symptoms and was statistically significant at 3 and 9 months following the therapy. A complete resolution in symptoms (VAS = 0) was observed in 38%–74% of women, depending on the symptom. Nine months after therapy, the prevalence of Candida albicans dropped from 80% to 30%, and a complete elimination of pathogens was detected in 64% of the women. The laser therapy appeared to be effective in the elimination of non‐albicans Candida species. A total of 86% of the patients reported being satisfied or very satisfied with the therapy. Only minor and transient adverse effects were recorded during the study.

Conclusion

Non‐ablative vaginal Er:YAG laser therapy proved to be a promising treatment for RVVC in women. The effect was achieved by improving their vaginal health by lowering the load of pathogenic yeast and by promoting the restoration of a favorable environment for normal microflora.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candidiasis, VulvovaginalLasers, Solid-StateHumansFemaleAdultRecurrenceTreatment OutcomePatient SatisfactionMiddle AgedYoung AdultCohort Studies

Stichwörter der Autor:innen

Er:YAG lasercandidiasisgenitalnon‐ablativerecurrent vaginal yeast infectionrecurrent vulvovaginal candidiasisvaginal

Autor:innen und Institutionen

  • Research and Health Department, Champagnat University, Mendoza, Argentina.
  • Clinica Espacio Gaspar, Olascoaga, Mendoza, Argentina.
  • Dr. Josué Vargas Mora Gynecology and Obstetrics Clinic, San José, Costa Rica.
  • Uroclinica: Paso de los Andes, Mendoza, Argentina.
  • Juan Fernando Bojanini Clinic, Medellín, Antioquia, Colombia.
  • Vulviscience Clinic: Av. Juan Bautista Alberdi, Buenos Aires, Argentina.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Gaspar, A., Calderon, A., Mora, J. V., Silva, J., Bojanini, J. F., Araujo, M. J., Geada, L. L., Ivanova, E., Helvacioglu, Y., Coello, P. P., Zelaschi, D., Lucas, M. F., Mitraud, L., Carneiro, V., Cogorno, M., Mikić, A. N., & Vasilescu, M. (2025). Exploring the Impact of Non‐Ablative Erbium Laser Therapy on Recurrent Vaginal Candidiasis. Lasers in Surgery and Medicine, 57(2), 187-194. https://doi.org/10.1002/lsm.23880

Vancouver

Gaspar A, Calderon A, Mora JV, Silva J, Bojanini JF, Araujo MJ, et al. Exploring the Impact of Non‐Ablative Erbium Laser Therapy on Recurrent Vaginal Candidiasis. Lasers in Surgery and Medicine. 2025;57(2):187-194. doi:10.1002/lsm.23880

BibTeX
@article{Gaspar2025,
  author = {Gaspar, Adrian and Calderon, Alicia and Mora, Josue Vargas and Silva, Joaquin and Bojanini, Juan Fernando and Araujo, Maria Jose and Geada, Leticia Lazzaleta and Ivanova, Elena and Helvacioglu, Yeksin and Coello, Pedro Peña and Zelaschi, Delfina and Lucas, Maria Fernanda and Mitraud, Larissa and Carneiro, Virginia and Cogorno, Mariela and Mikić, Aleksandra Novakov and Vasilescu, Mihaela},
  title = {Exploring the Impact of Non‐Ablative Erbium Laser Therapy on Recurrent Vaginal Candidiasis},
  journal = {Lasers in Surgery and Medicine},
  year = {2025},
  volume = {57},
  number = {2},
  pages = {187--194},
  doi = {10.1002/lsm.23880}
}
Kostenlos starten →